Resultados de la búsqueda 1001-1010 of 10349 for immunosuppressant drugs

  1. Oncología (médica) - Ensayos clínicos

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Other preclincal models to test drug effcicacy includes ex vivo 3D culture and 2D culture systems. In this study, we make and test preclinical models of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... drugs are safe for people to take. We also want to learn about the side ... The drug combination of acalabrutinib, durvalumab, and venetoclax is ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to validate the use of ex-vivo confocal microscopy for the assessment of skin specimens derived from Mohs surgery ...

  6. Trasplante de páncreas - Médicos y departamentos - Mayo Clinic

    Therapeutic drug monitoring of immunosuppressive drugs: A field constantly in motion. Therapeutic Drug Monitoring. 2025; doi:10.1097/FTD.0000000000001286 ...

  7. Oncología (médica) - Ensayos clínicos

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ensayos clínicos · International Registry For Men With Advanced Prostate Cancer (IRONMAN) · Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This study aims to create a registry for primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic ...